Schirpenbach Caroline, Seiler Lysann, Maser-Gluth Christiane, Beuschlein Felix, Reincke Martin, Bidlingmaier Martin
Ludwig-Maximilians-University, Medizinische Klinik Innenstadt, Munich, Germany.
Clin Chem. 2006 Sep;52(9):1749-55. doi: 10.1373/clinchem.2006.068502. Epub 2006 Jul 20.
Measurements of aldosterone have become more common since the recognition that primary aldosteronism is a more frequent cause of hypertension than previously believed. Our aim was to compare concentrations reported by 4 assays for samples obtained after saline infusion during dynamic testing.
We tested 104 participants (27 with primary aldosteronism, 30 with essential hypertension, and 47 healthy controls) with the intravenous saline infusion test (2.0 L isotonic saline over 4 h), with repetitive sampling. In all blood samples, aldosterone concentration was measured by an in-house RIA after extraction and chromatography, by 2 commercially available RIAs without extraction (Aldosterone Maia, Adaltis; Active Aldosterone, Diagnostics Systems Laboratories) and by an automated CLIA (Advantage, Nichols Institute Diagnostics).
Correlation coefficients for results of pairs of assays ranged from 0.74 to 0.98. Agreement between commercial assays and in-house RIA was best at the low to intermediate concentrations after saline infusion. Mean (SD) Adaltis and DSL RIA results were 2- to 3-times higher [healthy participants: 78 (25) ng/L and 56 (18) ng/L, respectively] than those obtained by Nichols CLIA [17 (8) ng/L] and in-house RIA [23 (18) ng/L]. Aldosterone concentrations measured by the Nichols CLIA were below the limit of detection (limit of the blank) in 27 of 47 healthy participants.
Aldosterone concentrations reported by the Adaltis and DSL nonextraction RIAs were consistently higher than those produced by the Nichols CLIA and the in-house RIA. The convenient Nichols CLIA showed better agreement with the in-house RIA, but the concentrations in healthy participants were frequently undetectable by this method. Uncritical application of cutoff values from the literature must be avoided.
自从认识到原发性醛固酮增多症是高血压比之前认为的更常见病因以来,醛固酮测量变得更为普遍。我们的目的是比较动态试验期间盐水输注后所获样本的4种检测方法报告的浓度。
我们对104名参与者(27例原发性醛固酮增多症患者、30例原发性高血压患者和47名健康对照者)进行静脉盐水输注试验(4小时内输注2.0 L等渗盐水),并重复采样。在所有血样中,醛固酮浓度通过提取和色谱分离后用内部放射免疫分析法(RIA)测量,通过2种无需提取的商用RIA(Adaltis公司的醛固酮Maia;Diagnostics Systems Laboratories公司的活性醛固酮)以及通过自动化化学发光免疫分析法(CLIA,Nichols Institute Diagnostics公司的优势检测法)测量。
各检测方法对结果的相关系数在0.74至0.98之间。盐水输注后低至中等浓度时,商用检测法与内部RIA之间的一致性最佳。Adaltis公司和Diagnostics Systems Laboratories公司RIA的平均(标准差)结果比Nichols CLIA法[17(8)ng/L]和内部RIA法[23(18)ng/L]所获结果高2至3倍[健康参与者分别为78(25)ng/L和56(18)ng/L]。Nichols CLIA法测量的醛固酮浓度在47名健康参与者中的27名低于检测限(空白限)。
Adaltis公司和Diagnostics Systems Laboratories公司的非提取RIA法报告的醛固酮浓度始终高于Nichols CLIA法和内部RIA法所测浓度。便捷的Nichols CLIA法与内部RIA法一致性更好,但该方法经常无法检测出健康参与者的浓度。必须避免不加批判地应用文献中的临界值。